Spyre Therapeutics, Inc. ( SYRE) - Stock Earnings
SYRE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -62.5 million USD | 90.5 million USD |
| 2026Q1 | -69.0 million USD | — USD |
| 2026Q2 | -36.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
SYRE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -338.8 million USD | 886000 USD |
| 2024 | -208.0 million USD | 886000 USD |
| 2025 | -155.2 million USD | — USD |
| 2026 Est. | — | — |
SYRE
Price: $108.92
52 week price:
Earnings Per Share: -1.93 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 9.1 billion